COVID-19 vaccines and the pandemic’s third year
The U.S. and Europe have shifted their focus toward booster doses, which have been proven critical in protection against omicron. As omicron lays the enduring threat from a mutating coronavirus and new variants, learn the latest developments in the COVID-19 vaccine. INCLUDED IN THIS TRENDLINE